Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
59.00    2.50 (4.42%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £55.91m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

AGM Statement

30 Sep 2019 11:00

RNS Number : 0365O
Panoply Holdings PLC (The)
30 September 2019
 

30 September 2019

The Panoply Holdings PLC

("The Panoply", or the "Group")

AGM Statement

At the Company's Annual General Meeting, being held today at 11am, Mark Smith, Chairman of The Panoply, will make the following statement:

"As highlighted at the time of our preliminary results, the Board is pleased with the progress made across the Group, delivering first year results ahead of our expectations at the time of the IPO. In a short space of time we have created a genuine disruptor to the large IT service providers, helped further by our largest acquisition to date, FutureGov.

As well as the performance of our established businesses, we have been particularly pleased with the progress made in our early stage investments, Greenshoot Labs and human+, both of which have gained market traction ahead of original expectations. Greenshoot Labs is the start-up acquired in February which provides digital solutions using Artificial Intelligence and Conversational Interfaces, whilst human+ was launched from within the Group, also in February, to provide robotic process automation services. Despite being early stage, I am pleased to report that they have both recently signed up several notable contract wins, with Greenshoot Labs working with The Defence Science and Technology Laboratory, Brunel University and a global telecoms client, and human+ working with the Food Standards Agency, University College London and NHS Wales.

These contracts underpin our confidence in these offerings and their growing importance in the digital transformation market. As such, we have been increasing investment in both of these areas to maximise the opportunity and believe that they can both deliver significant revenue streams in future periods. We therefore reiterate the statement made at the time of our annual report that we expect profitability in the year to be largely second half weighted.

We continue to be excited about The Panoply's growth prospects and look forward to providing further updates to shareholders."

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

Neil Shah

Luisa Orsini Baroni

 

 

 

Alma PR

(Financial PR)

Josh Royston

Susie Hudson

Kieran Breheny

panoply@almapr.co.uk

+44(0)203 405 0206

07780 901979

 

 

 

 

 

About The Panoply

 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses across Europe, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

 

More information is available at www.thepanoply.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSEMFWWFUSESU
Date   Source Headline
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding
1st Feb 202311:05 amRNSSecond Price Monitoring Extn
1st Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSBlocklisting Return
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSQ3 Trading Update
17th Jan 20237:00 amRNSDividend Payment Update
11th Jan 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
3rd Jan 20231:43 pmRNSTotal Voting Rights
12th Dec 202211:20 amRNSIssue of Shares, Transfer of Shares from EBT & TVR
9th Dec 20227:00 amRNSHolding(s) in Company
5th Dec 20225:14 pmRNSDirector/PDMR Shareholdings and TVR
30th Nov 20227:00 amRNSInterim Results
11th Nov 20227:00 amRNSIssue of Shares
1st Nov 20227:00 amRNSTotal Voting Rights
21st Oct 20227:00 amRNSConfirmation of board appointments
13th Oct 20227:00 amRNSIssue of Shares, PDMR dealings and TVR
10th Oct 20227:00 amRNSDirector/PDMR Shareholdings
7th Oct 20222:05 pmRNSSecond Price Monitoring Extn
7th Oct 20222:00 pmRNSPrice Monitoring Extension
7th Oct 20227:00 amRNSDirector/PDMR Shareholdings
6th Oct 20227:00 amRNSDirector/PDMR Shareholdings
5th Oct 20227:00 amRNSDirector/PDMR Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.